Ligan, Ronald N.
HRN: 26-78-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2025
CEFTRIAXONE 1G (VIAL)
03/08/2025
03/15/2025
IV
2gm
OD
Multiple Lacerated Wound
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes